tradmap

IRWD Ironwood Pharmaceuticals Inc

$4.28 -2.84%

Updated

Healthcare · Pharmaceutical Preparations

Ironwood Pharmaceuticals Inc (IRWD) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $707 million. Shares last traded at $4.28, 25.7% below their 52-week high. Over the past year the stock is up 248.0%. IRWD trades at a price-to-earnings ratio of 5.45, below the Pharmaceutical Preparations median of 17.31. Net profit margin is 33.4%, above the peer median of -8.9%. Revenue declined 15.7% year over year.

Market Cap
$707M
Shares Out
165.2M
EPS (TTM)
$0.47
P/E Ratio
9.11
P/S Ratio
1.82
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$5.76
52-Week Low
$1.01
Volume
83,385
Avg Vol (3m)
149,810.365

Performance

1W
+0.94%
1M
+3.63%
3M
+26.25%
6M
+18.23%
YTD
+0.23%
1Y
+247.97%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
51.98
SMA (50)
$4.17
SMA (200)
$3.93
Price vs SMA50
+2.52%
Price vs SMA200
+8.86%
ATR (14)
$0.21

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$389M
Net Income
$130M
Gross Margin
Operating Margin
60.1%
Net Margin
33.4%
Return on Equity
-80.2%
Return on Assets
45.5%
Current Ratio
6.06
Debt / Equity
-1.23
Revenue Growth (YoY)
-15.7%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.55 2026-08-06
Q1 2026 $0.24 2026-05-07
FY 2025 $0.15 2026-02-26
FY 2025 $0.23 2026-02-26
Q2 2026 $-0.09 2026-08-06
Q1 2026 $-0.23 2026-05-07

Full earnings history →

Pharmaceutical Preparations peers

IRWD vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated

P/E vs peers
5.45 / 17.31 med
-69% discount
P/S vs peers
1.82 / 11.11 med
-84% discount
Net margin vs peers
33.4% / -8.9% med
above median
1–14 of 14
LLYLilly (Eli)$1.09T40.8613.7033.5%-0.02%
JNJJohnson & Johnson$670.6B31.886.8521.5%+1.04%
ONCBeone Medicines Ltd.$535.9B817.2587.4310.7%+0.23%
ABBVAbbVie$459.8B72.877.149.8%-0.57%
MRKMerck$375.8B118.445.654.8%+0.44%
ABTAbbott Laboratories$189.5B30.204.2013.9%-1.50%
PFEPfizer$164.2B37.912.586.8%-0.76%
VRTXVertex Pharmaceuticals$141.5B32.1111.2435.0%+0.24%
BMYBristol Myers Squibb$139.1B14.982.8318.9%+0.62%
REGNRegeneron Pharmaceuticals$87.2B20.155.6127.9%-1.02%
TEVATeva Pharmaceutical Industries Ltd$42.6B60.412.464.1%-2.32%
ALNYAlnylam Pharmaceuticals$35.4B43.779.5221.8%-1.10%
ZTSZoetis$31.5B12.053.3127.5%+0.16%
RPRXRoyalty Pharma Plc$28.2B34.5611.1132.1%+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.